Abstract:Hot-melt extrusion (HME) is a technology increasingly common for the commercial production of pharmaceutical amorphous solid dispersions (ASDs), especially for poorly water-soluble active pharmaceutical ingredients (APIs). However, recrystallization of the APIs during dissolution must be prevented to maintain the supersaturation state enabled by ASD. Unfortunately, the amorphous formulation may be contaminated by seed crystals during the HME manufacturing process, which could lead to undesirable crystal growth during the dissolution process. In this study, the dissolution behavior of ritonavir ASD tablets prepared using both Form I and Form II polymorphs was examined, and the effects of different seed crystals on crystal growth rates were investigated. The aim was to understand how the presence of seed crystals can impact the dissolution of ritonavir, and to determine the optimal polymorph and seeding conditions for the production of ASDs. The results showed that both Form I and Form II ritonavir tablets had similar dissolution profiles, which were also similar to the reference listed drug (RLD). However, it was observed that the presence of seed crystals, particularly the metastable Form I seed, led to more precipitation compared to the stable Form II seed in all formulations. The Form I crystals that precipitated from the supersaturated solution were easily dispersed in the solution and could serve as seeds to facilitate crystal growth. On the other hand, Form II crystals tended to grow more slowly and presented as aggregates. The addition of both Form I and Form II seeds could affect their precipitation behaviors, and the amount and form of the seeds had significant effects on the precipitation process of the RLD tablets, as are the tablets prepared with different polymorphs. In conclusion, the study highlights the importance of minimizing the contamination risk of seed crystals during the manufacturing process and selecting the appropriate polymorph for the production of ASDs.

Crystallization Kinetics of Cooling Rifapention in the MSMPR Crystallizer

Study on Dissolution Thermodynamics and Cooling Crystallization of Rifamycin S

Crystallization kinetics of thermosensitive colloids probed by transmission spectroscopy.

Simulation of Crystallization Kinetics and Morphology During Nonisothermal Crystallization in Short Fiber Reinforced Composites

Kinetics Study On The Liquid Entrapment And Melt Transport Of Static And Falling-Film Melt Crystallization

Breakage-Facilitated Mixed-Suspension-Mixed-Product-Removal (MSMPR) Crystallization of Pharmaceutical Compounds

Crystal Modification of Rifapentine Using Different Solvents

Continuous Crystallization Process of Cefminox Sodium in MSMPR Crystallizer

Effect of different seed crystals on the supersaturation state of ritonavir tablets prepared by hot-melt extrusion

Multiscale Modeling and Simulation of Polymer Crystallization in Cooling Stage

Study on crystallization kinetics of calcium nitrate tetrahydrate

Use of Wet Milling Combined with Temperature Cycling to Minimize Crystal Agglomeration in a Sequential Antisolvent-Cooling Crystallization

Antisolvent crystallization of biapenem: Estimation of growth and nucleation kinetics

Antisolvent crystallization intensified by a jet crystallizer and a method for investigating crystallization kinetics

Monitoring the Crystallization Process of Methylprednisolone Hemisuccinate (MPHS) from Ethanol Solution by Combined ATR-FTIR- FBRM- PVM

Optimization of Batch Crystallization for Nickel Sulfate

Crystal Growth, Structure and Morphology of Rifapentine Methanol Solvate

Quantitative Process Design of 1-D Crystallization for Pure Melt

Growth, Characterization and Crystal Structure Analysis of Rifapentine

In-Situ Measurement of Particle Length Distribution by FBRM with Application to Needle- or Rod-Shape Crystallization Processes

The relevancy of controlled nanocrystallization on rifampicin characteristics and cytotoxicity